Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sana Biotechnology Inc (SANA)

Sana Biotechnology Inc (SANA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,862,619
  • Shares Outstanding, K 187,891
  • Annual Sales, $ 0 K
  • Annual Income, $ -285,310 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.13
Trade SANA with:

Options Overview

Details
  • Implied Volatility 80.03%
  • Historical Volatility 60.06%
  • IV Percentile 20%
  • IV Rank 27.56%
  • IV High 108.57% on 06/15/21
  • IV Low 69.17% on 06/25/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 107
  • Volume Avg (30-Day) 224
  • Put/Call OI Ratio 1.57
  • Today's Open Interest 236
  • Open Int (30-Day) 394

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.48
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.38 +32.66%
on 08/17/21
26.60 -3.35%
on 09/16/21
+5.76 (+28.87%)
since 08/16/21
3-Month
16.09 +59.79%
on 07/30/21
26.60 -3.35%
on 09/16/21
+3.33 (+14.88%)
since 06/16/21

Most Recent Stories

More News
Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the Morgan Stanley 19 Annual...

SANA : 25.71 (-0.66%)
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology

/PRNewswire/ -- MaxCyte, Inc. (Nasdaq: MXCT) (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the signing of a clinical and commercial license with Sana...

MXCN.LN : 1,025.000 (unch)
MXCT.LN : 1,065.000 (-0.47%)
MXCT : 14.96 (-2.48%)
SANA : 25.71 (-0.66%)
Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates

Presented data showing immune evasion and survival after transplantation of allogeneic cells into primates without immune suppression at ISSCR 2021

SANA : 25.71 (-0.66%)
Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

Facility to Support Allogeneic CAR T, Gene Therapy, and Stem Cell-Derived Therapies

SANA : 25.71 (-0.66%)
Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

First demonstration of the survival of allogeneic iPSCs transplanted into an immunocompetent non-human primate model without the need for immune suppression

SANA : 25.71 (-0.66%)
Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive Medicine and Health Security Initiative

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that , M.D. will help lead its Preemptive Medicine and Health Security initiative as Chief Medical Officer, and...

DNLI : 53.03 (+0.76%)
MRNA : 440.65 (+1.42%)
RUBY : 20.30 (+1.50%)
SANA : 25.71 (-0.66%)
MCRB : 6.51 (+2.52%)
Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that data will be presented during two plenary sessions at the International...

SANA : 25.71 (-0.66%)
Flagship Pioneering Closes $3.4 Billion Capital Pool to Drive Continued Breakthrough Innovations in Human Health and Sustainability

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced a significant expansion of its capital base to support founding and growing its next generation of human health...

FHTX : 13.07 (+2.75%)
SANA : 25.71 (-0.66%)
SGTX : 6.08 (+5.74%)
AXLA : 3.24 (+1.25%)
CDAK : 19.14 (+6.16%)
EVLO : 7.31 (+4.58%)
KLDO : 5.45 (+1.30%)
MRNA : 440.65 (+1.42%)
RUBY : 20.30 (+1.50%)
MCRB : 6.51 (+2.52%)
Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the Goldman Sachs 42 Annual...

SANA : 25.71 (-0.66%)
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture

, /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental...

AXLA : 3.24 (+1.25%)
CDAK : 19.14 (+6.16%)
DNLI : 53.03 (+0.76%)
EVLO : 7.31 (+4.58%)
FHTX : 13.07 (+2.75%)
KLDO : 5.45 (+1.30%)
MCRB : 6.51 (+2.52%)
MRNA : 440.65 (+1.42%)
RUBY : 20.30 (+1.50%)
SANA : 25.71 (-0.66%)
SGTX : 6.08 (+5.74%)

Business Summary

Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE.

See More

Key Turning Points

3rd Resistance Point 28.74
2nd Resistance Point 27.67
1st Resistance Point 26.69
Last Price 25.71
1st Support Level 24.64
2nd Support Level 23.57
3rd Support Level 22.59

See More

52-Week High 44.60
Fibonacci 61.8% 33.71
Fibonacci 50% 30.34
Fibonacci 38.2% 26.98
Last Price 25.71
52-Week Low 16.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar